Literature DB >> 15673506

Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites.

Haitham A Hussain1, Adam P Roberts1, Peter Mullany1.   

Abstract

Erythromycin resistance in Clostridium difficile strain 630 is conferred by a genetic element termed Tn5398 which contains two erm(B) genes: erm1(B) and erm2(B). An erythromycin-sensitive derivative of strain 630 (designated 630Deltaerm) was generated by spontaneous mutation after continuous subculture for 30 days. This strain had lost the erm2(B) gene from within Tn5398 but retained erm1(B). However, the strain could revert to erythromycin resistance at a frequency of 2.79 x 10(-8), although it still contained the deletion of erm2(B). The availability of C. difficile 630Deltaerm allowed the behaviour of Tn916DeltaE to be investigated in this strain. This element entered the genome at multiple sites indicating that it could be useful as an insertional mutagen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673506     DOI: 10.1099/jmm.0.45790-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  116 in total

1.  Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.

Authors:  Brandon R Anjuwon-Foster; Natalia Maldonado-Vazquez; Rita Tamayo
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

2.  Streptococcus pneumoniae transposon Tn1545/Tn6003 changes to Tn6002 due to spontaneous excision in circular form of the erm(B)- and aphA3-containing macrolide-aminoglycoside-streptothricin (MAS) element.

Authors:  Claudio Palmieri; Marina Mingoia; Orietta Massidda; Eleonora Giovanetti; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

3.  Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase.

Authors:  Brindar K Sandhu; Adrianne N Edwards; Sarah E Anderson; Emily C Woods; Shonna M McBride
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  A novel regulator controls Clostridium difficile sporulation, motility and toxin production.

Authors:  Adrianne N Edwards; Rita Tamayo; Shonna M McBride
Journal:  Mol Microbiol       Date:  2016-03-22       Impact factor: 3.501

5.  Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.

Authors:  Adrianne N Edwards; Kathryn L Nawrocki; Shonna M McBride
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

6.  Both, toxin A and toxin B, are important in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; Nigel P Minton
Journal:  Gut Microbes       Date:  2011-07-01

7.  Identification and characterization of glycoproteins on the spore surface of Clostridium difficile.

Authors:  Philippa C R Strong; Kelly M Fulton; Annie Aubry; Simon Foote; Susan M Twine; Susan M Logan
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

8.  The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.

Authors:  Ana M Oliveira Paiva; Leen de Jong; Annemieke H Friggen; Wiep Klaas Smits; Jeroen Corver
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

9.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production.

Authors:  Sarah Underwood; Shuang Guan; Vinod Vijayasubhash; Simon D Baines; Luke Graham; Richard J Lewis; Mark H Wilcox; Keith Stephenson
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.